Curated GI articles December 3rd, 2021: Big GI groups get bigger | AI in GI – future or hype? | New digital therapy for IBS

Curated GI articles December 3rd, 2021:
Big GI groups get bigger | AI in GI – future or hype? | New digital therapy for IBS

Four BIG TRENDS influencing the future of gastroenterology (NextServices)
Praveen Suthrum outlines the four big trends influencing GI today. The video provides the context for the GI Mastermind, a program to help you create the future of GI on your terms.

Big gastroenterology groups get bigger: 5 interesting deals in 2021 (Becker’s GI & Endoscopy)
Here are five of the most interesting acquisitions in gastroenterology this year compiled by Becker’s Healthcare.

AI in gastroenterology: The future or all hype? (Becker’s GI & Endoscopy)
Artificial intelligence has a growing presence in gastroenterology, many physicians are optimistic about the technology’s capacity to identify and characterize colon polyps.

Chronwell Partners with One GI to Bring Digital Therapeutics to Specialty Groups (PR Newswire)
One GI will deploy ChronWell’s LIVErHEALTHY™, Therapeutic Weight Management, and Digital Health products.

ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease (ACG)
The American College of Gastroenterology published an update to the association’s 2013 clinical guidelines on the diagnosis and management of gastroesophageal reflux disease.

metaMe Health Receives FDA Clearance for Regulora®, the First FDA-authorized Treatment Specifically for Abdominal Pain Due to IBS (PR web)
Regulora delivers behavioral therapy based on gut-directed hypnotherapy through a smartphone app.

Deep Learning Model Accurate In Reading Capsule Endoscopy Images (Gastroenterology & Endoscopy News)
A new deep learning model is over 90% accurate, and it requires a fraction of the time in detecting protruding colonic lesions observed through capsule endoscopy.

Are Physician-Owned Large Groups Better Than Employment? (Medscape)
Do large, physician-owned groups bring benefits that beat employment? And how do large groups compare with smaller practices and new opportunities, such as private equity?

Out-of-Pocket Costs Common With Colonoscopy After Fecal Screen (MedPage Today)
Patients needing colonoscopy after a non-invasive, stool-based test (SBT) often paid out of pocket for it, a study showed.

GIs should educate, promote value of colonoscopy to physicians, patients (Healio)
The value of colonoscopy for colorectal cancer screening is important from the perspective of the business aspect and also patient care aspect, according to a speaker at GI Outlook.

Iterative Scopes CE Marks SKOUT, its Innovative AI-Based Medical Device for Potential Colorectal Polyps Detection (Business Wire)
SKOUT helps gastroenterologists with potential colorectal polyp detection during colonoscopy examinations with the aim of improving clinical decision making and patient care.

Microbiome signature may identify IBS patients who respond to FODMAP diet (The Limbic)
A distinct gut microbiome signature has been identified in people with IBS who are responsive to low FODMAP dietary therapy.

New Trials in GI Cancers (Non-CRC): Could Your Patient Benefit? (Medscape)
A number of clinical trials in noncolorectal gastrointestinal cancers have opened in recent months. Maybe patients could benefit from being enrolled.

Ubiquitous food additive alters human microbiota and intestinal environment (Medical Xpress)
New clinical research indicates that a widely used food additive, carboxymethylcellulose, alters the intestinal environment of healthy persons, perturbing levels of beneficial bacteria and nutrients.

COVID-19 vaccines: Lower serologic response among IBD, rheumatic diseases (MD edge)
The researchers examined the post-vaccine serologic response rate in patients with IMIDs versus controls without IMIDs. Serologic response was evaluated separately after one or two vaccine doses.

The Scope: Dr. Brian Dooreck on Diagnosing CRC (Gastroenterology & Endoscopy News)
Brian Dooreck, MD, of Pembroke Pines, Fla., explains why gastroenterologists can–and must–do a better job of communicating with their patients about a new diagnosis of colorectal cancer.

Gastrointestinal function in diabetes is affected regardless of asymptomatic appearance (Journal of Internal Medicine)
The research shows asymptomatic individuals with diabetes have altered gastrointestinal function associated with age, cardiac vagal tone, and glycaemic control.

Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis (The Lancet GI & Hepatology)
The analysis is aimed to compare the relative efficacy and safety of biologics and small molecule drugs for the treatment of patients with moderate-to-severe ulcerative colitis.

More Hot headlines in GI

ICYMI: [Interview] Dr. Sravanthi Parasa: “When a phone can recognize my face, why can’t software recognize a polyp?”

10 steps for leading your practice through a crisis (Healio)

Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib (Dove Press)

Suono Bio, Inc. Announces Exclusive Patent License with MIT for Portfolio of Granted IP Covering Formulation-Independent Drug Delivery (Valdosta Daily Times)

PET-based tool detects liver inflammation in NAFLD (Smart Brief)

The sole endoscopy center to earn Leapfrog’s patient care excellence award (Becker’s GI & Endoscopy)

Medtronic receives Health Canada licence for GI Genius™ intelligent endoscopy module (Yahoo Finance)

Florida GI center adds AI-driven colonoscopy system (Becker’s GI & Endoscopy)

Educating Outpatients for Bowel Preparation Before Colonoscopy Using Conventional Methods vs Virtual Reality Videos Plus Conventional Methods (JAMA Network)

The top 10 healthcare M&A targets in 2022 (Fierce Healthcare)

Universal testing, access to clinical pharmacist reduced barriers to HCV treatment (Healio)

Videos: Interviews with GI Leaders  (NextServices)

_

COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.